2024-513663-10-01
Not yet recruiting
Phase 1
A Phase 1 study of GSK5764227 in participants with advanced solid tumors
Glaxosmithkline Research & Development Limited, Glaxosmithkline Research & Development Limited12 sites in 3 countries112 target enrollmentStarted: August 11, 2025Last updated:
Overview
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
- Glaxosmithkline Research & Development Limited, Glaxosmithkline Research & Development Limited
- Enrollment
- 112
- Locations
- 12
Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 65+ years (18-64 Years, 65+ Years)
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
EU GSK Clinical Trials Call Center
Scientific
Glaxosmithkline Research & Development Limited
Study Sites (12)
Loading locations...
Similar Trials
Recruiting
Not Applicable
A Phase 1 study of GSK5764227 in participants with advanced solid tumorsjRCT2031240381GlaxoSmithKline K.K.15
Not yet recruiting
Phase 1
First-in-Human trial of DS9051b in participants with advanced solid tumors2025-521886-28-00Daiichi Sankyo Inc.15
Completed
Not Applicable
A Study of GSK3511294 in Participants With Severe Asthma With an Eosinophilic PhenotypejRCT2031200411GlaxoSmithKline K.K.375
Not yet recruiting
Phase 1
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants and Healthy Chinese and Japanese Participants2024-514186-18-00Glaxosmithkline Research & Development Limited15
Unknown
Phase 1
Phase I Clinical Study of RG7167 in Patients with Advanced Solid TumorsjRCT2080221451Chugai Pharmaceutical Co., Ltd.36